Dr. Farah Louise Lim is a Medical Oncologist at St Bartholomew’s Cancer centre, London, where she leads the lung cancer clinical trials unit.

 

Her research focuses on novel therapies for early- and late-stage lung cancer, particularly antibody–drug conjugates (ADCs) and bispecific antibodies, alongside the development of biomarkers to guide therapy selection and improve patient outcomes.

Dr Louise Lim has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

AstraZeneca, Astellas, BMS, Gilead, MSD, Merck-Serono, Pfizer & Roche.